# Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The ECLIPSE Trial

Study · id `cardio:ct-nct03108456` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03108456](<https://clinicaltrials.gov/study/NCT03108456>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03108456

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 2005 participants.

## Technical summary

Registry record NCT03108456. Randomized; no masking; primary purpose treatment. Start 2017-03-27 (actual); primary completion 2024-06-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 2005 participants (enrolled count; ClinicalTrials.gov record NCT03108456, source copy `cardio:ctgov-nct03108456-2023-10-06`, retrieved 2026-10-26)
- Started: 2017-03-27 (actual) (ClinicalTrials.gov record NCT03108456, source copy `cardio:ctgov-nct03108456-2023-10-06`, retrieved 2026-10-26)
- Primary completion: 2024-06-12 (anticipated) (ClinicalTrials.gov record NCT03108456, source copy `cardio:ctgov-nct03108456-2023-10-06`, retrieved 2026-10-26)
- Completion: 2025-06-12 (anticipated) (ClinicalTrials.gov record NCT03108456, source copy `cardio:ctgov-nct03108456-2023-10-06`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT03108456, source copy `cardio:ctgov-nct03108456-2023-10-06`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03108456-2023-10-06`, retrieved 2026-10-26)

## The registry's words

- Brief title: Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The ECLIPSE Trial
- Acronym: ECLIPSE
- Condition: Coronary Artery Disease
- Condition: Ischemic Heart Disease
- Condition: Non ST Segment Elevation Myocardial Infarction
- Intervention (Device): Orbital Atherectomy
- Intervention (Device): Balloon
- Lead sponsor: Abbott Medical Devices
- Lead sponsor class: INDUSTRY
- Collaborator: Cardiovascular Research Foundation, New York
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Abbott (`cardio:abbott`)
- Registry lists this organization as a collaborator: Cardiovascular Research Foundation, New York (`cardio:org-cardiovascular-research-foundation-new-york`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Orbital atherectomy versus balloon angioplasty before drug-eluting stent implantation in severely calcified lesions eligible for both treatment strategies (ECLIPSE): a multicentre, open-label, randomised trial (`cardio:pubmed-40174596`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Calcium Modification After Orbital Atherectomy and Balloon Angioplasty in Severely Calcified Lesions: The ECLIPSE OCT Substudy (`cardio:pubmed-41332372`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 6e92d226773d7f1442b20e89f0e919522571ad564a2f4d7d6babfcfdf8554b3b
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
